Abiopharma

🔍 Galloreese David (Executive)

Company: Datadog, Inc. (DDOG)

Report Date: 2026-04-01

Detailed Transactions and Holdings:

• Acquired 25,354 shares of Class A Common Stock (Direct)
  Date: 2026-04-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 130,886.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Represents the number of shares of Class A Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Class A Common Stock. The shares underlying the RSUs vest as to 12/48 of the shares on March 1, 2027 and the remainder of the shares vest in 12 equal installments on each June 1, September 1, December 1 and March 1 thereafter, subject to the Reporting Person remaining in Continuous Service (as defined in the Issuer's 2019 Equity Incentive Plan) of the Issuer as of each such date.